awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37965616-72EE99FC-0F31-4EE3-91AE-B314DC1010B5
Q37965616-72EE99FC-0F31-4EE3-91AE-B314DC1010B5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37965616-72EE99FC-0F31-4EE3-91AE-B314DC1010B5
Oxaliplatin: a review of approved uses.
P2860
Q37965616-72EE99FC-0F31-4EE3-91AE-B314DC1010B5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37965616-72EE99FC-0F31-4EE3-91AE-B314DC1010B5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f3897e713e9478206b525724860d696c5af46035
P2860
Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate.